Methods for treating retinopathy with extended therapeutic effect
AssigneeAllergan, Inc.
InventorsScott Whitcup, David Weber
Life of this patent
Estimating the term…
Abstract
Methods for treating and preventing retinopathic conditions by administering a glucocorticoid to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy.
Claims32
A method for treating a retinopathy, the method comprising the steps of:
- a) administering to the posterior chamber of an eye of a patient having a retinopathy a glucocorticoid capable of reducing the severity or progression of at least one symptom of the retinopathy;
- b) permitting substantially all of the glucocorticoid to dissolve in the vitreous of the eye, and;
- c) obtaining a continued reduction in the severity or progression of the at least one symptom at a time after a therapeutic amount of the glucocorticoid has ceased to be present in the posterior chamber.
A method of preventing the presentation of at least one symptom of a retinopathy comprising administering to the vitreous of a mammal at risk of such presentation a glucocorticoid at a dosage effective to reduce the severity of such symptom in a different patient suffering from the retinopathy, comprising administering the dosage to the vitreous of a patient's eye before the presentation of the at least one symptom.
Dependencies are inferred from the claim text.